11 апреля 2013, 17:05
Аналитика на 11 апреля
Спайдер торгуется на премаркете около уровня вчерашнего закрытия.
SPY (внутридневной график) боковое движение на премаркете. Сопротивление 159.00 Поддержка: 158.50
Ожидаемая макроэкономическая статистика:
Gapping up:
In reaction to strong earnings/guidance/SSS: RAD +12.8%, ZUMZ +8%, BBBY +1.5%, COST +0.9% (light volume).
M&A news: LIFE 1.1% (continued M&A related speculation, WSJ discusses ongoing M&A speculation in LIFE as PE firms BX, KKR, and CG remain as possible buyout group).
Other news:
ACAD +25.5% (announces expedited path to NDA Filing for Pimavanserin following meeting with FDA), AEZS +25.3% (presents encouraging updated data on its LHRH receptor-targeted Disorazol Z Cytotoxic Conjugates at AACR Meeting), AMRS +18.5% (describe breakthrough in development of anti-malarial drug precursor; Sanofi (SNY) utilizing Amyris engineered yeast strains to produce drug ingredient at scale), NMR +8.2% and TM +3.9% (following strength in overseas trading — Nikkei 2.0%), CTIC +5.3% (announces NICE issue draft guidance on PIXUVRI), PSTI +3% (United Therapeutics receives regulatory approval to commence Phase I study of Pluristem's PLX-PAD cells for pulmonary arterial hypertension), TI +2.4% (Telecom Italia Board considering to allow Hutchison Whampoa to purchase stake in TI, according to reports), ELN +1.5% (still checking), UL +1.1% (still checking), NBL +1.1% (trading higher following CEO comments, see company as doubling), IP +1% (reports out indicate Dan Loeb's Third Point LLC has increased its stake in International Paper).
Analyst comments: BYD +3% (upgraded to Overweight from Equal-Weight at Morgan Stanley), DGX +1.2% (upgraded to Buy from Neutral at Goldman), XRX +0.4% (Xerox initiated with an Overweight at Piper Jaffray), AMGN +0.3% ($125 from $106 at Lazard)
Gapping down:
In reaction to disappointing earnings/guidance/SSS: FTNT -17.7% (also downgraded by multiple analysts), APOG -7.5%, IART -7% (issues voluntary recall of certain products manufactured in its Anasco, Puerto Rico facility; expects revs lower by ~$8-11 mln in Q1, also downgraded by ,ultiple analysts), PIR -3.6%, YUM -3%, PFMT -1.1%, LTD -1%.
Select metals/mining stocks trading lower: MT -1.8%, GOLD -1.5%, AU -1.1% (downgraded to Hold from Buy at Societe Generale), BBL -0.7%, BHP -0.5%, SLV -0.3%,.
PC/tech names lower following disappointing IDC report: HPQ -5.5%, MSFT -3.9% (also downgraded at Goldman and Nomura), INTC -2.3%, TDC -0.8%
A few FTNT/security tech companies under pressure: FIRE -3.6%, PANW -2.8%, CHKP -1.6%
Other news: AFFY -17% (disclsoed that AFFY and Takeda Pharmaceutical entered into the Fourth Amendment to the February 13, 2006 and June 27, 2006 collaboration andlLicense agreements), SSH -8.2% (has commenced underwritten public offering of common stock pursuant to effective shelf registration previously filed with the SEC), SGYP -5.2% (prices 16.375 mln shares of common stock for gross proceeds of ~$90 mln ), INFI -4% (announces pricing of secondary offering of common stock by existing shareholders Beacon Company and Rosebay Medical Company ), FSC -3.8% (commences public offering of 13.5 mln shares of common stock), ROYL -2.4% (modestly pulling back), PKX -1.6% (still checking), RLGY -0.6% (prices 35 mln share offering by certain funds affiliated with Apollo Global Management (APO) at $44.00 per share ).
Отчеты компаний:
Вчера после закрытия: RT RELL APOG CHC
Сегодня перед открытием: NTIC CBSH IGTE PIR RAD LEDS
Торговые идеи NYSEи NASDAQ:
FTNT– очень сильное падение на постмаркете и премаркете, реакция на Guidance. Ключевые уровни 18.00 и 19.00, работаем от них.
BBBY– отчет и гайденс на текущий год. При закрепелнии 67.00 смотрим акцию в лонг, ниже 66.00 – шорт.
YUM– опубликовали результаты по продажам на фоне птичьего гриппа в Китае. Снижение продаж примерно на 13%, смотрим акцию в шорт ниже 64.00, выше 65.50 – лонг.
ACAD– опубликован новый документ FDA по результатам 3его этапа испытаний препарата компании. Очень сильный рост на премаркете, ниже 12.00 смотрим сетапы в шорт с потенциалом от 50 центов до доллара.
Оригинал статьи: http://shark-traders.com/blog/analitika-na-11-aprelya/
- Европейские индексы на положительной территории.
- Nikkei +1,96 %
SPY (внутридневной график) боковое движение на премаркете. Сопротивление 159.00 Поддержка: 158.50
Ожидаемая макроэкономическая статистика:
- Initial Claims (8:30am)- Briefing.com consensus 365K
- March Import/Export Prices (8:30am)- Prior 0.0%, +0.6%, respectively
- Natural as Inventories (10:30am)
- 30-year Bond Auction (1pm)
Gapping up:
In reaction to strong earnings/guidance/SSS: RAD +12.8%, ZUMZ +8%, BBBY +1.5%, COST +0.9% (light volume).
M&A news: LIFE 1.1% (continued M&A related speculation, WSJ discusses ongoing M&A speculation in LIFE as PE firms BX, KKR, and CG remain as possible buyout group).
Other news:
ACAD +25.5% (announces expedited path to NDA Filing for Pimavanserin following meeting with FDA), AEZS +25.3% (presents encouraging updated data on its LHRH receptor-targeted Disorazol Z Cytotoxic Conjugates at AACR Meeting), AMRS +18.5% (describe breakthrough in development of anti-malarial drug precursor; Sanofi (SNY) utilizing Amyris engineered yeast strains to produce drug ingredient at scale), NMR +8.2% and TM +3.9% (following strength in overseas trading — Nikkei 2.0%), CTIC +5.3% (announces NICE issue draft guidance on PIXUVRI), PSTI +3% (United Therapeutics receives regulatory approval to commence Phase I study of Pluristem's PLX-PAD cells for pulmonary arterial hypertension), TI +2.4% (Telecom Italia Board considering to allow Hutchison Whampoa to purchase stake in TI, according to reports), ELN +1.5% (still checking), UL +1.1% (still checking), NBL +1.1% (trading higher following CEO comments, see company as doubling), IP +1% (reports out indicate Dan Loeb's Third Point LLC has increased its stake in International Paper).
Analyst comments: BYD +3% (upgraded to Overweight from Equal-Weight at Morgan Stanley), DGX +1.2% (upgraded to Buy from Neutral at Goldman), XRX +0.4% (Xerox initiated with an Overweight at Piper Jaffray), AMGN +0.3% ($125 from $106 at Lazard)
Gapping down:
In reaction to disappointing earnings/guidance/SSS: FTNT -17.7% (also downgraded by multiple analysts), APOG -7.5%, IART -7% (issues voluntary recall of certain products manufactured in its Anasco, Puerto Rico facility; expects revs lower by ~$8-11 mln in Q1, also downgraded by ,ultiple analysts), PIR -3.6%, YUM -3%, PFMT -1.1%, LTD -1%.
Select metals/mining stocks trading lower: MT -1.8%, GOLD -1.5%, AU -1.1% (downgraded to Hold from Buy at Societe Generale), BBL -0.7%, BHP -0.5%, SLV -0.3%,.
PC/tech names lower following disappointing IDC report: HPQ -5.5%, MSFT -3.9% (also downgraded at Goldman and Nomura), INTC -2.3%, TDC -0.8%
A few FTNT/security tech companies under pressure: FIRE -3.6%, PANW -2.8%, CHKP -1.6%
Other news: AFFY -17% (disclsoed that AFFY and Takeda Pharmaceutical entered into the Fourth Amendment to the February 13, 2006 and June 27, 2006 collaboration andlLicense agreements), SSH -8.2% (has commenced underwritten public offering of common stock pursuant to effective shelf registration previously filed with the SEC), SGYP -5.2% (prices 16.375 mln shares of common stock for gross proceeds of ~$90 mln ), INFI -4% (announces pricing of secondary offering of common stock by existing shareholders Beacon Company and Rosebay Medical Company ), FSC -3.8% (commences public offering of 13.5 mln shares of common stock), ROYL -2.4% (modestly pulling back), PKX -1.6% (still checking), RLGY -0.6% (prices 35 mln share offering by certain funds affiliated with Apollo Global Management (APO) at $44.00 per share ).
Отчеты компаний:
Вчера после закрытия: RT RELL APOG CHC
Сегодня перед открытием: NTIC CBSH IGTE PIR RAD LEDS
Торговые идеи NYSEи NASDAQ:
FTNT– очень сильное падение на постмаркете и премаркете, реакция на Guidance. Ключевые уровни 18.00 и 19.00, работаем от них.
BBBY– отчет и гайденс на текущий год. При закрепелнии 67.00 смотрим акцию в лонг, ниже 66.00 – шорт.
YUM– опубликовали результаты по продажам на фоне птичьего гриппа в Китае. Снижение продаж примерно на 13%, смотрим акцию в шорт ниже 64.00, выше 65.50 – лонг.
ACAD– опубликован новый документ FDA по результатам 3его этапа испытаний препарата компании. Очень сильный рост на премаркете, ниже 12.00 смотрим сетапы в шорт с потенциалом от 50 центов до доллара.
Оригинал статьи: http://shark-traders.com/blog/analitika-na-11-aprelya/
0 Комментариев
23:08
genubat, а хде радость на лице — за проделанный труд???
— Подразумевает — откат/распил?
Газпром пробивает новое дно - стоит ли подбирать с расчётом на отскок дохлой кошки?
⛽️Сегодня ажиотаж происходит вокруг Газпрома. Свыше 100к сделок за день.
Вероятно люди закладывают позитив п...
Франция продолжает активные закупки российского СПГ
Несмотря на всю негативную риторику Франция продолжает закупки российского СПГ. Так из ноябрьских отгрузок 626 тысяч тонн было отгружено во франц...
Представляем новую функциональность модуля «Нефть и нефтепродукты» Терминала Сиала - сделки вторичного рынка по покупке-продаже танкеров
В рамках функциональности доступны как первичные данные по с...
Завтра растём или падаем по индексу ММВБ? Ну шо друзья! Приободрились? Настроение хоть маленько поднялось от зелёненьких росточков? Сегодня рынок чуть подрос… Сигнализирует наверно тем, у кого бапки о...
Qwert Asdfg (humera), признаю, ты у нас маладец
Опять твари тащат на тонком рынке
23:08
ны рынке ОФЗ (фикс, дал) идет самая настоящая скупка, ее масштабы и методы начинают пугать, мой вопрос рынку КУДА он херачит с таким опережением, почему не разгон а именно скупка: бумаги уже дня три(э...
Тетерин Андрей, а я по 40р опять залезу.